White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Aβ42 levels

Acta Neurologica Scandinavica

Volumn 118, Issue 6, 2008, Pages 373-378

  Stenset, V ^a   Hofoss, D ^a   Johnsen, L ^a   Skinningsrud, A ^a   Berstad, A E ^a,c   Negaard, A ^a,d   Reinvang, I ^b   Gjerstad, L ^c   Fladby, T ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

A 42; Cerebrovascular disease; Cognitive impairment; CSF; White matter lesions

Indexed keywords

AGED; ARTICLE; CEREBROSPINAL FLUID LEVEL; COGNITION; COGNITIVE DEFECT; CONTROL GROUP; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; RETROSPECTIVE STUDY; WHITE MATTER;

EID: 55949131788     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01045.x     Document Type: Article

References (39)

1. Awad IA, Johnson PC, Spetzler RF, Hodak JA. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke 1986 17 : 1090 7.
2. Fazekas F, Kleinert R, Offenbacher H et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993 43 : 1683 9.
3. Van Swieten JC, Van Den Hout JH, Van Ketel BA, Hijdra A, Wokke JH, Van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991 114 : 761 74.
4. Ward NS, Brown MM. Leukoaraiosis. In : Donnan GA, Norrving B, Bamford J, Bogousslasky J, eds. Subcortical stroke, 2nd edn. Oxford : Oxford University Press, 2002 47 66.
5. De Reuck J. The human periventricular arterial blood supply and the anatomy of cerebral infarctions. Eur Neurol 1971 5 : 321 34.
6. Salamon G, Boudouresques J, Combalbert A, Khalil R, Faure J, Giudicelli G. [Lenticulo-striated arteries. Arteriographic study. Their importance in the diagnosis of intracerebral hematomas]. Rev Neurol (Paris) 1966 114 : 361 73.
7. Catani M, Ffytche DH. The rises and falls of disconnection syndromes. Brain 2005 128 : 2224 39.
8. Nordahl CW, Ranganath C, Yonelinas AP, Decarli C, Fletcher E, Jagust WJ. White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci 2006 18 : 418 29.
9. O'sullivan M, Morris RG, Huckstep B, Jones DK, Williams SC, Markus HS. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004 75 : 441 7.
10. De Leeuw FE, De Kleine M, Frijns CJ, Fijnheer R, Van Gijn J, Kappelle LJ. Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular disease. Ann N Y Acad Sci 2002 977 : 306 14.
11. Roman GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 2002 204 : 7 10.
12. Roman GC, Sachdev P, Royall DR et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 2004 226 : 81 7.
13. Chalmers K, Wilcock G, Love S. Contributors to white matter damage in the frontal lobe in Alzheimer's disease. Neuropathol Appl Neurobiol 2005 31 : 623 31.
14. Au R, Massaro JM, Wolf PA et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol 2006 63 : 246 50.
15. Breteler MM, Van Swieten JC, Bots ML et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994 44 : 1246 52.
16. Burns JM, Church JA, Johnson DK et al. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. Arch Neurol 2005 62 : 1870 6.
17. De Groot JC, De Leeuw FE, Oudkerk M et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000 47 : 145 51.
18. Hunt AL, Orrison WW, Yeo RA et al. Clinical significance of MRI white matter lesions in the elderly. Neurology 1989 39 : 1470 4.
19. Longstreth WT Jr., Manolio TA, Arnold A et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996 27 : 1274 82.
20. Reed BR, Mungas DM, Kramer JH et al. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain 2007 130 : 731 9.
21. Sabri O, Ringelstein EB, Hellwig D et al. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 1999 30 : 556 66.
22. Jokinen H, Kalska H, Mantyla R et al. Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2006 77 : 28 33.
23. Prins ND, Van Dijk EJ, Den Heijer T et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005 128 : 2034 41.
24. Soderlund H, Nilsson LG, Berger K et al. Cerebral changes on MRI and cognitive function: the CASCADE study. Neurobiol Aging 2006 27 : 16 23.
25. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. Jama 1997 277 : 813 17.
26. Vermeer SE, Prins ND, Den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003 348 : 1215 22.
27. Stenset V, Johnsen L, Kocot D et al. Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42. Neurology 2006 67 : 830 3.
28. Wiltfang J, Lewczuk P, Riederer P et al. Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J Biol Psychiatry 2005 6 : 69 84.
29. Stefani A, Bernardini S, Panella M et al. AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. J Neurol Sci 2005 237 : 83 8.
30. Andreasen N, Hesse C, Davidsson P et al. Cerebrospinal fluid beta-amyloid (1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 1999 56 : 673 80.
31. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003 2 : 605 13.
32. Strozyk D, Blennow K, White LR, Launer LJ. CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 2003 60 : 652 6.
33. Fagan AM, Mintun MA, Mach RH et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta 42 in humans. Ann Neurol 2006 59 : 512 19.
34. Forsberg A, Engler H, Almkvist O et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 2007 (e-pub ahead of print).
35. Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007 6 : 734 46.
36. Schwamm LH, Van Dyke C, Kiernan RJ, Merrin EL, Mueller J. The Neurobehavioral Cognitive Status Examination: comparison with the Cognitive Capacity Screening Examination and the Mini-Mental State Examination in a neurosurgical population. Ann Intern Med 1987 107 : 486 91.
37. Wahlund LO, Barkhof F, Fazekas F et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001 32 : 1318 22.
38. Hulstaert F, Blennow K, Ivanoiu A et al. Improved discrimination of AD patients using beta-amyloid (1-42) and tau levels in CSF. Neurology 1999 52 : 1555 62.
39. Dufouil C, Chalmers J, Coskun O et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005 112 : 1644 50.